Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Useful Contacts |
  6. Site Map |
  7. Help
  1. Font size

    Reduce font size Increase font size  
 
 
Rare diseases & Multiple sclerosis

Contact us

Medical Information Services

To obtain more information about our products, please call:

Australia
tel: 1800 818 806

New Zealand
tel: 0800 283 684

Content :

Rare Diseases & Multiple sclerosis

Through Genzyme, our rare diseases and multiple sclerosis division, we are pioneers in the development and delivery of transformative therapies for people affected by rare and debilitating diseases.

 

There are nearly 7,000 identified rare diseases and many that have no treatment available. While each disease is rare, collectively they affect millions of people. This has been the focus of Genzyme for more than 30 years as the leader in the development of targeted therapies for rare diseases.

Today, thanks to Genzyme’s enormous research efforts and successes, people benefit from treatments or enzyme replacement therapies for Gaucher’s disease, Pompe disease, mucopolysaccharidosis type I, and Fabry disease.

Genzyme is also addressing unmet medical need for people who have multiple sclerosis (MS), which is the second most frequent debilitating neurological disorder in young adults after accidents.

Module :

Corporate information

Corporate information